Vinorelbine Accord Healthcare 10 mg/ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vinorelbine accord healthcare 10 mg/ml inf. sol. (conc.) i.v. vial

accord healthcare b.v. - vinorelbine tartrate 13,85 mg/ml - eq. vinorelbine 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - vinorelbine tartrate 13.85 mg/ml - vinorelbine

Vinorelbine Accord Healthcare 10 mg/ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vinorelbine accord healthcare 10 mg/ml inf. sol. (conc.) i.v. vial

accord healthcare b.v. - vinorelbine tartrate 13,85 mg/ml - eq. vinorelbine 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - vinorelbine tartrate 13.85 mg/ml - vinorelbine

Vinorelbine Sandoz 10 mg/ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vinorelbine sandoz 10 mg/ml inf. sol. (conc.) i.v. vial

sandoz sa-nv - vinorelbine tartrate 13,85 mg/ml - eq. vinorelbine 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - vinorelbine tartrate 13.85 mg/ml - vinorelbine

Vinorelbine Sandoz 10 mg/ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vinorelbine sandoz 10 mg/ml inf. sol. (conc.) i.v. vial

sandoz sa-nv - vinorelbine tartrate 13,85 mg/ml - eq. vinorelbine 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - vinorelbine tartrate 13.85 mg/ml - vinorelbine

Vinorelbin Eugia 10 mg/ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vinorelbin eugia 10 mg/ml inf. sol. (conc.) i.v. vial

eugia pharma (malta) ltd. - vinorelbine tartrate 13,85 mg/ml - eq. vinorelbine 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - vinorelbine tartrate 13.85 mg/ml - vinorelbine

Vinorelbin Eugia 10 mg/ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

vinorelbin eugia 10 mg/ml inf. sol. (conc.) i.v. vial

eugia pharma (malta) ltd. - vinorelbine tartrate 13,85 mg/ml - eq. vinorelbine 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - vinorelbine tartrate 13.85 mg/ml - vinorelbine

Navelbine 10 mg/1 ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

navelbine 10 mg/1 ml inf. sol. (conc.) i.v. vial

pierre fabre médicament - vinorelbine tartrate 13,85 mg/ml - eq. vinorelbine 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - vinorelbine tartrate 13.85 mg/ml - vinorelbine

Navelbine 40 mg/4 ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

navelbine 40 mg/4 ml inf. sol. (conc.) i.v. vial

pierre fabre médicament - vinorelbine tartrate 13,85 mg/ml - eq. vinorelbine 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - vinorelbine tartrate 13.85 mg/ml - vinorelbine

Navelbine 50 mg/5 ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

navelbine 50 mg/5 ml inf. sol. (conc.) i.v. vial

pierre fabre médicament - vinorelbine tartrate 13,85 mg/ml - eq. vinorelbine 10 mg/ml - concentrate for solution for infusion - 10 mg/ml - vinorelbine tartrate 13.85 mg - vinorelbine

VINORELBINE- vinorelbine injection, solution United States - English - NLM (National Library of Medicine)

vinorelbine- vinorelbine injection, solution

hospira, inc. - vinorelbine tartrate (unii: 253gqw851q) (vinorelbine - unii:q6c979r91y) - vinorelbine 10 mg in 1 ml - vinorelbine injection, usp is indicated: none pregnancy category d risk summary vinorelbine can cause fetal harm when administered to a pregnant woman. in animal reproduction studies in mice and rabbits, embryo and fetal toxicity were observed with administration of vinorelbine at doses approximately 0.33 and 0.18 times the human therapeutic dose, respectively. if this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, apprise the patient of the potential hazard to a fetus. animal data in a mouse embryofetal development study, administration of a single dose of vinorelbine at a dose level of 9 mg/m2 or greater (approximately 0.33 times the recommended human dose based on body surface area) was embryotoxic and fetotoxic. vinorelbine was embryotoxic and fetotoxic to pregnant rabbits when administered every 6 days during the period of organogenesis at doses of 5.5 mg/m2 (approximately 0.18 times the recommended human dose based on body surface area) or greater. at doses t